The Effect of Two Different Oral Care Solutions on Ventilator-Associated Pneumonia and Oral Health of Mechanically Ventilated Patients in the Intensive Care Unit

Launched by SAGLIK BILIMLERI UNIVERSITESI · May 4, 2025

Keywords

ClinConnect Summary

Ventilator-associated pneumonia (VAP) is defined as pulmonary parenchymal infection in patients exposed to invasive mechanical ventilation for at least 48 hours and is a part of intensive care unit (ICU)-acquired pneumonia. Ventilator-associated pneumonia is the most common intensive care unit (ICU)-acquired infection among patients receiving invasive mechanical ventilation. When the VAP data of surgical and medical ICUs of thirty-six developing countries, including our country, for the years 2013-2018 were evaluated; the average VAP rate was determined as 11.47 per 1000 ventilator days. It...

Gender

ALL

Eligibility criteria

• • Inclusion Criteria:• Being 18 years of age or older
• • Requiring mechanical ventilation for at least 48 hours
• • Not having a diagnosis of aspiration pneumonia
• • Having a Clinical Lung Infection Score (CPIS) \<6 on the first day
• • Not having a diagnosis of pneumonia or COVID
• • Not having facial or oral trauma
• • Being within the first 24 hours of the intubation process
• • Not having a medical impediment to elevating the head of the bed 30o
• Exclusion Criteria:
• • Not accepting to participate in the study
• • Termination of MV support for less than 48 hours
• • Being allergic to any of the solutions to be used in oral care
• • Being diagnosed with immunodeficiency
• • Having thrombocytopenia, leukopenia and oral aphthae, stomatitis, candidiasis, gingivitis
• • Using immunosuppressive drugs